Estimated Effectiveness of 2024-2025 COVID-19 Vaccination Against Severe COVID-19
Kevin Ma, Alexander Webber, Adam S. Lauring, Emily E. Bendall et autres
us (code pays fourni par la source)
13 citations
JAMA Network Open
Anne Kaniclides
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
11Publications signalées
1172Citations signalées
0Affiliations récentes
Les domaines associés
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesInfluenza Virus Research StudiesVaccine Coverage and HesitancyRespiratory viral infections research
Les publications récentes
Effectiveness of the Original Monovalent Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccination Series Against Hospitalization for COVID-19–Associated Venous Thromboembolism
David N. Hager, Yuwei Zhu, Ine Sohn, William B. Stubblefield et autres
us (code pays fourni par la source)
0 citations
The Journal of Infectious Diseases
Vaccine Effectiveness Against Influenza A–Associated Hospitalization, Organ Failure, and Death: United States, 2022–2023
Nathaniel M. Lewis, Yuwei Zhu, Ithan D. Peltan, Manjusha Gaglani et autres
us (code pays fourni par la source)
37 citations
Clinical Infectious Diseases
Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021–August 2022
Noah Kojima, Katherine Adams, Wesley H. Self, Manjusha Gaglani et autres
us (code pays fourni par la source)
34 citations
Clinical Infectious Diseases
Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021–April 2022
Nathaniel M. Lewis, Nancy L. Murray, Katherine Adams, Diya Surie et autres
us (code pays fourni par la source)
13 citations
Open Forum Infectious Diseases
Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021
Nathaniel M. Lewis, Eric A. Naioti, Wesley H. Self, Adit A. Ginde et autres
us (code pays fourni par la source)
23 citations
The Journal of Infectious Diseases
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021
Wesley H. Self, Mark W. Tenforde, Jillian P. Rhoads, Manjusha Gaglani et autres
us (code pays fourni par la source)
454 citations
MMWR Morbidity and Mortality Weekly Report
Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults — United States, March–July 2021
Mark W. Tenforde, Wesley H. Self, Eric A. Naioti, Adit A. Ginde et autres
us (code pays fourni par la source)
246 citations
MMWR Morbidity and Mortality Weekly Report
Comparison of a frailty short interview to a validated frailty index in adults hospitalized for acute respiratory illness
Joshua G. Petrie, Emily T. Martin, Yuwei Zhu, Dayna Wyatt et autres
us (code pays fourni par la source)
9 citations
Vaccine
Data resource profile: Household Influenza Vaccine Evaluation (HIVE) Study
Arnold S. Monto, Ryan E. Malosh, Richard B. Evans, Adam S. Lauring et autres
us (code pays fourni par la source)
31 citations
International Journal of Epidemiology
Effects of Influenza Vaccination in the United States During the 2017–2018 Influenza Season
Melissa A. Rolfes, Brendan Flannery, Jessie R. Chung, Alissa O’Halloran et autres
us (code pays fourni par la source)
312 citations
Clinical Infectious Diseases
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.